✦ LIBER ✦

PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)

✍ Scribed by Hutchings, A.; Tolley, K.; Achana, F.; Brereton, N.J.; Lebmeier, M.; Mesa, O.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB37 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ K Kolasa; M Niewada; J Puelles Fernandez de Troconiz; R Townsend; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PDB44 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ W Erhardt; K Bergenheim; R Townsend; J Puelles Fernandez de Troconiz; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB9 Cost-Effectiveness Analysis of Saxa

✍ E.E. Arinina; M. Rashyd 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB22 COST-EFFECTIVENESS OF INSULIN GLAR

✍ ME Minshall; SL Tunis; L Sauriol 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB36 COST-EFFECTIVENESS OF THE ROUX-EN-

✍ ME Minshall; T Swan; B Slusarek; S Ikramuddin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB